nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—Methylprednisolone—multiple sclerosis	0.039	0.232	CbGbCtD
Alitretinoin—ABCB1—Mitoxantrone—multiple sclerosis	0.0284	0.169	CbGbCtD
Alitretinoin—ABCB1—Betamethasone—multiple sclerosis	0.0253	0.151	CbGbCtD
Alitretinoin—ABCB1—Prednisolone—multiple sclerosis	0.025	0.149	CbGbCtD
Alitretinoin—ABCB1—Prednisone—multiple sclerosis	0.0236	0.141	CbGbCtD
Alitretinoin—CRABP2—pineal body—multiple sclerosis	0.018	0.135	CbGeAlD
Alitretinoin—ABCB1—Dexamethasone—multiple sclerosis	0.0147	0.0878	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—multiple sclerosis	0.0118	0.0705	CbGbCtD
Alitretinoin—CRABP1—brainstem—multiple sclerosis	0.00621	0.0466	CbGeAlD
Alitretinoin—CRABP1—retina—multiple sclerosis	0.00599	0.045	CbGeAlD
Alitretinoin—CRABP1—medulla oblongata—multiple sclerosis	0.00433	0.0325	CbGeAlD
Alitretinoin—CRABP1—midbrain—multiple sclerosis	0.00396	0.0297	CbGeAlD
Alitretinoin—RARG—retina—multiple sclerosis	0.00395	0.0297	CbGeAlD
Alitretinoin—CRABP2—medulla oblongata—multiple sclerosis	0.00392	0.0294	CbGeAlD
Alitretinoin—CRABP1—spinal cord—multiple sclerosis	0.00386	0.029	CbGeAlD
Alitretinoin—CRABP2—spinal cord—multiple sclerosis	0.00349	0.0262	CbGeAlD
Alitretinoin—RXRG—medulla oblongata—multiple sclerosis	0.00342	0.0257	CbGeAlD
Alitretinoin—CRABP1—nervous system—multiple sclerosis	0.00326	0.0244	CbGeAlD
Alitretinoin—CRABP1—central nervous system—multiple sclerosis	0.00313	0.0235	CbGeAlD
Alitretinoin—RXRG—midbrain—multiple sclerosis	0.00313	0.0235	CbGeAlD
Alitretinoin—CRABP1—cerebellum—multiple sclerosis	0.00306	0.023	CbGeAlD
Alitretinoin—RXRG—spinal cord—multiple sclerosis	0.00305	0.0229	CbGeAlD
Alitretinoin—CRABP2—nervous system—multiple sclerosis	0.00294	0.0221	CbGeAlD
Alitretinoin—RXRA—nervous system—multiple sclerosis	0.00293	0.022	CbGeAlD
Alitretinoin—CRABP2—central nervous system—multiple sclerosis	0.00283	0.0213	CbGeAlD
Alitretinoin—RXRA—central nervous system—multiple sclerosis	0.00282	0.0212	CbGeAlD
Alitretinoin—CRABP2—cerebellum—multiple sclerosis	0.00277	0.0208	CbGeAlD
Alitretinoin—RXRG—nervous system—multiple sclerosis	0.00257	0.0193	CbGeAlD
Alitretinoin—CRABP1—brain—multiple sclerosis	0.00249	0.0187	CbGeAlD
Alitretinoin—RARB—cerebellum—multiple sclerosis	0.00248	0.0186	CbGeAlD
Alitretinoin—RXRG—central nervous system—multiple sclerosis	0.00248	0.0186	CbGeAlD
Alitretinoin—RXRB—nervous system—multiple sclerosis	0.00242	0.0181	CbGeAlD
Alitretinoin—RXRB—central nervous system—multiple sclerosis	0.00233	0.0175	CbGeAlD
Alitretinoin—RXRB—cerebellum—multiple sclerosis	0.00228	0.0171	CbGeAlD
Alitretinoin—CRABP2—brain—multiple sclerosis	0.00225	0.0169	CbGeAlD
Alitretinoin—RXRA—brain—multiple sclerosis	0.00224	0.0168	CbGeAlD
Alitretinoin—RARG—nervous system—multiple sclerosis	0.00215	0.0161	CbGeAlD
Alitretinoin—RARG—central nervous system—multiple sclerosis	0.00207	0.0155	CbGeAlD
Alitretinoin—RARG—cerebellum—multiple sclerosis	0.00202	0.0152	CbGeAlD
Alitretinoin—RARA—nervous system—multiple sclerosis	0.00202	0.0151	CbGeAlD
Alitretinoin—RARB—brain—multiple sclerosis	0.00201	0.0151	CbGeAlD
Alitretinoin—RXRG—brain—multiple sclerosis	0.00197	0.0148	CbGeAlD
Alitretinoin—RARA—central nervous system—multiple sclerosis	0.00194	0.0146	CbGeAlD
Alitretinoin—RARA—cerebellum—multiple sclerosis	0.0019	0.0143	CbGeAlD
Alitretinoin—RXRB—brain—multiple sclerosis	0.00185	0.0139	CbGeAlD
Alitretinoin—RARG—brain—multiple sclerosis	0.00164	0.0123	CbGeAlD
Alitretinoin—RARA—brain—multiple sclerosis	0.00154	0.0116	CbGeAlD
Alitretinoin—ABCB1—retina—multiple sclerosis	0.000706	0.0053	CbGeAlD
Alitretinoin—ABCB1—medulla oblongata—multiple sclerosis	0.00051	0.00383	CbGeAlD
Alitretinoin—ABCB1—midbrain—multiple sclerosis	0.000467	0.0035	CbGeAlD
Alitretinoin—ABCB1—spinal cord—multiple sclerosis	0.000455	0.00341	CbGeAlD
Alitretinoin—RXRA—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000396	0.00174	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000395	0.00173	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000395	0.00173	CbGpPWpGaD
Alitretinoin—ABCB1—nervous system—multiple sclerosis	0.000384	0.00288	CbGeAlD
Alitretinoin—CRABP1—Metabolism—CYP24A1—multiple sclerosis	0.000379	0.00167	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP27B1—multiple sclerosis	0.000379	0.00167	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP24A1—multiple sclerosis	0.000379	0.00167	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP27B1—multiple sclerosis	0.000379	0.00167	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000371	0.00163	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000371	0.00163	CbGpPWpGaD
Alitretinoin—ABCB1—central nervous system—multiple sclerosis	0.000369	0.00277	CbGeAlD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000369	0.00162	CbGpPWpGaD
Alitretinoin—ABCB1—cerebellum—multiple sclerosis	0.000361	0.00271	CbGeAlD
Alitretinoin—RARG—Gene Expression—U2AF2—multiple sclerosis	0.000354	0.00156	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000354	0.00156	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000353	0.00155	CbGpPWpGaD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000351	0.00154	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GPC5—multiple sclerosis	0.000347	0.00152	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GPC5—multiple sclerosis	0.000347	0.00152	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000347	0.00152	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000347	0.00152	CbGpPWpGaD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.000345	0.00152	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.00034	0.00149	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000338	0.00148	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—HNRNPA1—multiple sclerosis	0.000324	0.00142	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—U2AF2—multiple sclerosis	0.000324	0.00142	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000321	0.00141	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—PGR—multiple sclerosis	0.00032	0.00141	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—U2AF2—multiple sclerosis	0.000318	0.0014	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—HNRNPA1—multiple sclerosis	0.000318	0.0014	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000315	0.00138	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HNRNPA1—multiple sclerosis	0.000305	0.00134	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—U2AF2—multiple sclerosis	0.000305	0.00134	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HNRNPA1—multiple sclerosis	0.000305	0.00134	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—U2AF2—multiple sclerosis	0.000305	0.00134	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000297	0.00131	CbGpPWpGaD
Alitretinoin—ABCB1—brain—multiple sclerosis	0.000293	0.0022	CbGeAlD
Alitretinoin—RXRG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000293	0.00129	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—RRM1—multiple sclerosis	0.000288	0.00126	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—RRM1—multiple sclerosis	0.000288	0.00126	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PGR—multiple sclerosis	0.000287	0.00126	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000284	0.00125	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—ZFP36L1—multiple sclerosis	0.00028	0.00123	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PGR—multiple sclerosis	0.000276	0.00121	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000276	0.00121	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.00027	0.00119	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000268	0.00118	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000264	0.00116	CbGpPWpGaD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000259	0.00114	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000258	0.00113	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000258	0.00113	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000256	0.00113	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000256	0.00113	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ZFP36L1—multiple sclerosis	0.000256	0.00113	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ZFP36L1—multiple sclerosis	0.000251	0.0011	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ZFP36L1—multiple sclerosis	0.000241	0.00106	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ZFP36L1—multiple sclerosis	0.000241	0.00106	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—STAT3—multiple sclerosis	0.00024	0.00105	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—FAS—multiple sclerosis	0.00024	0.00105	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000237	0.00104	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000234	0.00103	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000233	0.00102	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ZNF746—multiple sclerosis	0.000229	0.00101	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000227	0.000999	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—STAT3—multiple sclerosis	0.000226	0.000991	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000224	0.000983	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000223	0.00098	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000223	0.00098	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TGFB1—multiple sclerosis	0.000222	0.000977	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000218	0.000956	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PABPC1—multiple sclerosis	0.000217	0.000954	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000216	0.000948	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000214	0.000941	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000214	0.000941	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000211	0.000928	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000211	0.000928	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PTBP1—multiple sclerosis	0.00021	0.000921	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TGFB1—multiple sclerosis	0.000209	0.000918	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—multiple sclerosis	0.000208	0.000912	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000208	0.000912	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000206	0.000904	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000205	0.0009	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000205	0.000899	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—VDR—multiple sclerosis	0.000201	0.000882	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.0002	0.000878	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PABPC1—multiple sclerosis	0.000199	0.000873	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—RPL5—multiple sclerosis	0.000196	0.000861	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—multiple sclerosis	0.000195	0.000858	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PABPC1—multiple sclerosis	0.000195	0.000856	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—VDR—multiple sclerosis	0.000193	0.000846	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—VDR—multiple sclerosis	0.000193	0.000846	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000192	0.000842	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000192	0.000842	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000187	0.000821	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PABPC1—multiple sclerosis	0.000187	0.000821	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PABPC1—multiple sclerosis	0.000187	0.000821	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.00018	0.000791	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—RPL5—multiple sclerosis	0.000179	0.000787	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000176	0.000774	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—RPL5—multiple sclerosis	0.000176	0.000772	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000175	0.000767	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000175	0.000767	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000169	0.00074	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RPL5—multiple sclerosis	0.000169	0.00074	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—RPL5—multiple sclerosis	0.000169	0.00074	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—multiple sclerosis	0.000168	0.000736	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PRNP—multiple sclerosis	0.000166	0.000728	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000166	0.000728	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—BCHE—multiple sclerosis	0.000165	0.000725	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—BCHE—multiple sclerosis	0.000165	0.000725	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SRM—multiple sclerosis	0.000163	0.000716	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000162	0.000713	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000161	0.000706	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.00016	0.000704	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000159	0.000699	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000159	0.000699	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—U2AF2—multiple sclerosis	0.000159	0.000698	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HNRNPA1—multiple sclerosis	0.000159	0.000698	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000158	0.000694	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—multiple sclerosis	0.000158	0.000692	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000157	0.00069	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000155	0.00068	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000155	0.000679	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PGR—multiple sclerosis	0.000154	0.000678	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000154	0.000677	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000154	0.000675	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000151	0.000665	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—POMC—multiple sclerosis	0.000151	0.000663	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000151	0.000662	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.00015	0.000657	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000144	0.000631	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000144	0.00063	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Alitretinoin—Epistaxis—Methotrexate—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Alitretinoin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisolone—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Alitretinoin—Tachycardia—Triamcinolone—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Alitretinoin—Mental disorder—Prednisone—multiple sclerosis	0.000143	0.000303	CcSEcCtD
Alitretinoin—Nausea—Azathioprine—multiple sclerosis	0.000143	0.000303	CcSEcCtD
Alitretinoin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000143	0.000303	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000143	0.000627	CbGpPWpGaD
Alitretinoin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000142	0.000302	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—multiple sclerosis	0.000142	0.000301	CcSEcCtD
Alitretinoin—Erythema—Prednisone—multiple sclerosis	0.000142	0.000301	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000142	0.000623	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000142	0.000301	CcSEcCtD
Alitretinoin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000142	0.000301	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000141	0.0003	CcSEcCtD
Alitretinoin—Convulsion—Betamethasone—multiple sclerosis	0.000141	0.0003	CcSEcCtD
Alitretinoin—Convulsion—Dexamethasone—multiple sclerosis	0.000141	0.0003	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PGR—multiple sclerosis	0.000141	0.00062	CbGpPWpGaD
Alitretinoin—Hypertension—Dexamethasone—multiple sclerosis	0.000141	0.000299	CcSEcCtD
Alitretinoin—Hypertension—Betamethasone—multiple sclerosis	0.000141	0.000299	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.00014	0.000616	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00014	0.000613	CbGpPWpGaD
Alitretinoin—Asthenia—Mitoxantrone—multiple sclerosis	0.000139	0.000296	CcSEcCtD
Alitretinoin—Myalgia—Betamethasone—multiple sclerosis	0.000139	0.000294	CcSEcCtD
Alitretinoin—Myalgia—Dexamethasone—multiple sclerosis	0.000139	0.000294	CcSEcCtD
Alitretinoin—RARB—Gene Expression—PGR—multiple sclerosis	0.000138	0.000608	CbGpPWpGaD
Alitretinoin—Anxiety—Dexamethasone—multiple sclerosis	0.000138	0.000293	CcSEcCtD
Alitretinoin—Anxiety—Betamethasone—multiple sclerosis	0.000138	0.000293	CcSEcCtD
Alitretinoin—Discomfort—Dexamethasone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Alitretinoin—Discomfort—Betamethasone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Alitretinoin—Haemoglobin—Methotrexate—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Alitretinoin—Hypotension—Methylprednisolone—multiple sclerosis	0.000137	0.00029	CcSEcCtD
Alitretinoin—Pain—Prednisolone—multiple sclerosis	0.000136	0.000289	CcSEcCtD
Alitretinoin—Hepatitis—Methotrexate—multiple sclerosis	0.000136	0.000289	CcSEcCtD
Alitretinoin—Haemorrhage—Methotrexate—multiple sclerosis	0.000136	0.000289	CcSEcCtD
Alitretinoin—Pharyngitis—Methotrexate—multiple sclerosis	0.000135	0.000287	CcSEcCtD
Alitretinoin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000135	0.000286	CcSEcCtD
Alitretinoin—Vision blurred—Prednisone—multiple sclerosis	0.000134	0.000284	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—multiple sclerosis	0.000134	0.000284	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000134	0.000283	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000133	0.000283	CcSEcCtD
Alitretinoin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000133	0.000282	CcSEcCtD
Alitretinoin—Oedema—Dexamethasone—multiple sclerosis	0.000133	0.000282	CcSEcCtD
Alitretinoin—Oedema—Betamethasone—multiple sclerosis	0.000133	0.000282	CcSEcCtD
Alitretinoin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000133	0.000282	CcSEcCtD
Alitretinoin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000133	0.000282	CcSEcCtD
Alitretinoin—RARA—Gene Expression—PGR—multiple sclerosis	0.000133	0.000583	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PGR—multiple sclerosis	0.000133	0.000583	CbGpPWpGaD
Alitretinoin—Insomnia—Triamcinolone—multiple sclerosis	0.000133	0.000281	CcSEcCtD
Alitretinoin—Insomnia—Methylprednisolone—multiple sclerosis	0.000132	0.000281	CcSEcCtD
Alitretinoin—Infection—Dexamethasone—multiple sclerosis	0.000132	0.00028	CcSEcCtD
Alitretinoin—Infection—Betamethasone—multiple sclerosis	0.000132	0.00028	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000132	0.00028	CcSEcCtD
Alitretinoin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000132	0.000279	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000131	0.000279	CcSEcCtD
Alitretinoin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000131	0.000279	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—multiple sclerosis	0.000131	0.000279	CcSEcCtD
Alitretinoin—Anaemia—Prednisone—multiple sclerosis	0.000131	0.000278	CcSEcCtD
Alitretinoin—Shock—Dexamethasone—multiple sclerosis	0.000131	0.000278	CcSEcCtD
Alitretinoin—Shock—Betamethasone—multiple sclerosis	0.000131	0.000278	CcSEcCtD
Alitretinoin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000131	0.000277	CcSEcCtD
Alitretinoin—Nervous system disorder—Betamethasone—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Alitretinoin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Alitretinoin—Agitation—Prednisone—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00013	0.000276	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00013	0.000276	CcSEcCtD
Alitretinoin—Tachycardia—Betamethasone—multiple sclerosis	0.00013	0.000276	CcSEcCtD
Alitretinoin—Tachycardia—Dexamethasone—multiple sclerosis	0.00013	0.000276	CcSEcCtD
Alitretinoin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000129	0.000274	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—PTPRC—multiple sclerosis	0.000129	0.000566	CbGpPWpGaD
Alitretinoin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000129	0.000273	CcSEcCtD
Alitretinoin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000129	0.000273	CcSEcCtD
Alitretinoin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000129	0.000273	CcSEcCtD
Alitretinoin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000129	0.000273	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000128	0.000563	CbGpPWpGaD
Alitretinoin—Malaise—Prednisone—multiple sclerosis	0.000128	0.000272	CcSEcCtD
Alitretinoin—Eye disorder—Methotrexate—multiple sclerosis	0.000127	0.00027	CcSEcCtD
Alitretinoin—Syncope—Prednisone—multiple sclerosis	0.000127	0.00027	CcSEcCtD
Alitretinoin—Tinnitus—Methotrexate—multiple sclerosis	0.000127	0.00027	CcSEcCtD
Alitretinoin—Anorexia—Dexamethasone—multiple sclerosis	0.000127	0.000269	CcSEcCtD
Alitretinoin—Anorexia—Betamethasone—multiple sclerosis	0.000127	0.000269	CcSEcCtD
Alitretinoin—Urticaria—Prednisolone—multiple sclerosis	0.000127	0.000269	CcSEcCtD
Alitretinoin—Fatigue—Triamcinolone—multiple sclerosis	0.000126	0.000268	CcSEcCtD
Alitretinoin—Fatigue—Methylprednisolone—multiple sclerosis	0.000126	0.000268	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—ZFP36L1—multiple sclerosis	0.000126	0.000552	CbGpPWpGaD
Alitretinoin—Pain—Triamcinolone—multiple sclerosis	0.000125	0.000266	CcSEcCtD
Alitretinoin—Loss of consciousness—Prednisone—multiple sclerosis	0.000125	0.000265	CcSEcCtD
Alitretinoin—Hypotension—Dexamethasone—multiple sclerosis	0.000124	0.000264	CcSEcCtD
Alitretinoin—Hypotension—Betamethasone—multiple sclerosis	0.000124	0.000264	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—multiple sclerosis	0.000124	0.000262	CcSEcCtD
Alitretinoin—Vomiting—Mitoxantrone—multiple sclerosis	0.000124	0.000262	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—multiple sclerosis	0.000123	0.000261	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—multiple sclerosis	0.000123	0.00026	CcSEcCtD
Alitretinoin—Rash—Mitoxantrone—multiple sclerosis	0.000122	0.00026	CcSEcCtD
Alitretinoin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000122	0.00026	CcSEcCtD
Alitretinoin—Chills—Methotrexate—multiple sclerosis	0.000122	0.000259	CcSEcCtD
Alitretinoin—Headache—Mitoxantrone—multiple sclerosis	0.000122	0.000258	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000121	0.000257	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000121	0.000257	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—multiple sclerosis	0.000121	0.000256	CcSEcCtD
Alitretinoin—Myalgia—Prednisone—multiple sclerosis	0.000121	0.000256	CcSEcCtD
Alitretinoin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000121	0.000256	CcSEcCtD
Alitretinoin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000121	0.000256	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—multiple sclerosis	0.00012	0.000256	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—multiple sclerosis	0.00012	0.000256	CcSEcCtD
Alitretinoin—Insomnia—Dexamethasone—multiple sclerosis	0.00012	0.000255	CcSEcCtD
Alitretinoin—Insomnia—Betamethasone—multiple sclerosis	0.00012	0.000255	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00012	0.000255	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00012	0.000254	CcSEcCtD
Alitretinoin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000119	0.000254	CcSEcCtD
Alitretinoin—Paraesthesia—Betamethasone—multiple sclerosis	0.000119	0.000254	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—multiple sclerosis	0.000119	0.000253	CcSEcCtD
Alitretinoin—Mental disorder—Methotrexate—multiple sclerosis	0.000119	0.000253	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—multiple sclerosis	0.000119	0.000252	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—multiple sclerosis	0.000119	0.000252	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000118	0.00052	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT3—multiple sclerosis	0.000118	0.000516	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000117	0.000249	CcSEcCtD
Alitretinoin—Dyspepsia—Betamethasone—multiple sclerosis	0.000117	0.000249	CcSEcCtD
Alitretinoin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000117	0.000249	CcSEcCtD
Alitretinoin—Urticaria—Triamcinolone—multiple sclerosis	0.000116	0.000247	CcSEcCtD
Alitretinoin—Urticaria—Methylprednisolone—multiple sclerosis	0.000116	0.000247	CcSEcCtD
Alitretinoin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000116	0.000246	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000116	0.000246	CcSEcCtD
Alitretinoin—Oedema—Prednisone—multiple sclerosis	0.000116	0.000246	CcSEcCtD
Alitretinoin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000116	0.000245	CcSEcCtD
Alitretinoin—Decreased appetite—Betamethasone—multiple sclerosis	0.000116	0.000245	CcSEcCtD
Alitretinoin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000116	0.000245	CcSEcCtD
Alitretinoin—Nausea—Mitoxantrone—multiple sclerosis	0.000115	0.000245	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000115	0.000506	CbGpPWpGaD
Alitretinoin—Infection—Prednisone—multiple sclerosis	0.000115	0.000244	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CYP24A1—multiple sclerosis	0.000115	0.000504	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP27B1—multiple sclerosis	0.000115	0.000504	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000115	0.000244	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000115	0.000244	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—multiple sclerosis	0.000115	0.000244	CcSEcCtD
Alitretinoin—Fatigue—Dexamethasone—multiple sclerosis	0.000115	0.000243	CcSEcCtD
Alitretinoin—Fatigue—Betamethasone—multiple sclerosis	0.000115	0.000243	CcSEcCtD
Alitretinoin—Shock—Prednisone—multiple sclerosis	0.000114	0.000242	CcSEcCtD
Alitretinoin—Pain—Dexamethasone—multiple sclerosis	0.000114	0.000241	CcSEcCtD
Alitretinoin—Pain—Betamethasone—multiple sclerosis	0.000114	0.000241	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—multiple sclerosis	0.000114	0.000241	CcSEcCtD
Alitretinoin—Tachycardia—Prednisone—multiple sclerosis	0.000113	0.00024	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—multiple sclerosis	0.000112	0.000239	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000112	0.000493	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000112	0.000238	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000112	0.000491	CbGpPWpGaD
Alitretinoin—Vision blurred—Methotrexate—multiple sclerosis	0.000112	0.000237	CcSEcCtD
Alitretinoin—Anorexia—Prednisone—multiple sclerosis	0.00011	0.000234	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00011	0.000234	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—multiple sclerosis	0.00011	0.000233	CcSEcCtD
Alitretinoin—Feeling abnormal—Betamethasone—multiple sclerosis	0.00011	0.000233	CcSEcCtD
Alitretinoin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00011	0.000233	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—multiple sclerosis	0.000109	0.000479	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000109	0.000231	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000109	0.000231	CcSEcCtD
Alitretinoin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000108	0.000229	CcSEcCtD
Alitretinoin—RARG—Gene Expression—VDR—multiple sclerosis	0.000108	0.000474	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000108	0.000229	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—multiple sclerosis	0.000107	0.000227	CcSEcCtD
Alitretinoin—Urticaria—Dexamethasone—multiple sclerosis	0.000106	0.000224	CcSEcCtD
Alitretinoin—Urticaria—Betamethasone—multiple sclerosis	0.000106	0.000224	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000106	0.000224	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000105	0.000463	CbGpPWpGaD
Alitretinoin—Dizziness—Prednisolone—multiple sclerosis	0.000105	0.000224	CcSEcCtD
Alitretinoin—Asthenia—Triamcinolone—multiple sclerosis	0.000105	0.000223	CcSEcCtD
Alitretinoin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000105	0.000223	CcSEcCtD
Alitretinoin—Abdominal pain—Betamethasone—multiple sclerosis	0.000105	0.000223	CcSEcCtD
Alitretinoin—Body temperature increased—Betamethasone—multiple sclerosis	0.000105	0.000223	CcSEcCtD
Alitretinoin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000105	0.000223	CcSEcCtD
Alitretinoin—RXRA—Metabolism—GPC5—multiple sclerosis	0.000105	0.000461	CbGpPWpGaD
Alitretinoin—Asthenia—Methylprednisolone—multiple sclerosis	0.000105	0.000223	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—multiple sclerosis	0.000105	0.000222	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—multiple sclerosis	0.000104	0.000221	CcSEcCtD
Alitretinoin—Pruritus—Triamcinolone—multiple sclerosis	0.000104	0.00022	CcSEcCtD
Alitretinoin—Cough—Methotrexate—multiple sclerosis	0.000103	0.00022	CcSEcCtD
Alitretinoin—Pruritus—Methylprednisolone—multiple sclerosis	0.000103	0.00022	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—multiple sclerosis	0.000103	0.000218	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000103	0.000451	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000102	0.00045	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000102	0.000449	CbGpPWpGaD
Alitretinoin—Dyspepsia—Prednisone—multiple sclerosis	0.000102	0.000216	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TNF—multiple sclerosis	0.000102	0.000447	CbGpPWpGaD
Alitretinoin—Chest pain—Methotrexate—multiple sclerosis	0.000101	0.000214	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—multiple sclerosis	0.000101	0.000214	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—multiple sclerosis	0.000101	0.000214	CcSEcCtD
Alitretinoin—Decreased appetite—Prednisone—multiple sclerosis	0.000101	0.000214	CcSEcCtD
Alitretinoin—Rash—Prednisolone—multiple sclerosis	0.0001	0.000213	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—multiple sclerosis	0.0001	0.000213	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—VDR—multiple sclerosis	0.0001	0.000441	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.0001	0.000213	CcSEcCtD
Alitretinoin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0001	0.000212	CcSEcCtD
Alitretinoin—Fatigue—Prednisone—multiple sclerosis	9.98e-05	0.000212	CcSEcCtD
Alitretinoin—Headache—Prednisolone—multiple sclerosis	9.98e-05	0.000212	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—multiple sclerosis	9.98e-05	0.000212	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—APOE—multiple sclerosis	9.93e-05	0.000436	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—APOE—multiple sclerosis	9.93e-05	0.000436	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—multiple sclerosis	9.93e-05	0.000436	CbGpPWpGaD
Alitretinoin—Constipation—Prednisone—multiple sclerosis	9.9e-05	0.00021	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—VDR—multiple sclerosis	9.86e-05	0.000433	CbGpPWpGaD
Alitretinoin—Confusional state—Methotrexate—multiple sclerosis	9.76e-05	0.000207	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—PABPC1—multiple sclerosis	9.74e-05	0.000428	CbGpPWpGaD
Alitretinoin—Dizziness—Triamcinolone—multiple sclerosis	9.69e-05	0.000206	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—multiple sclerosis	9.68e-05	0.000205	CcSEcCtD
Alitretinoin—RARB—Gene Expression—VDR—multiple sclerosis	9.67e-05	0.000425	CbGpPWpGaD
Alitretinoin—Dizziness—Methylprednisolone—multiple sclerosis	9.67e-05	0.000205	CcSEcCtD
Alitretinoin—Infection—Methotrexate—multiple sclerosis	9.62e-05	0.000204	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisone—multiple sclerosis	9.54e-05	0.000203	CcSEcCtD
Alitretinoin—Asthenia—Betamethasone—multiple sclerosis	9.54e-05	0.000203	CcSEcCtD
Alitretinoin—Asthenia—Dexamethasone—multiple sclerosis	9.54e-05	0.000203	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	9.53e-05	0.000418	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Methotrexate—multiple sclerosis	9.49e-05	0.000202	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—multiple sclerosis	9.48e-05	0.000201	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—multiple sclerosis	9.47e-05	0.000201	CcSEcCtD
Alitretinoin—Nausea—Prednisolone—multiple sclerosis	9.47e-05	0.000201	CcSEcCtD
Alitretinoin—Pruritus—Dexamethasone—multiple sclerosis	9.41e-05	0.0002	CcSEcCtD
Alitretinoin—Pruritus—Betamethasone—multiple sclerosis	9.41e-05	0.0002	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—multiple sclerosis	9.4e-05	0.0002	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	9.36e-05	0.000411	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Methotrexate—multiple sclerosis	9.36e-05	0.000199	CcSEcCtD
Alitretinoin—Vomiting—Triamcinolone—multiple sclerosis	9.32e-05	0.000198	CcSEcCtD
Alitretinoin—Vomiting—Methylprednisolone—multiple sclerosis	9.3e-05	0.000197	CcSEcCtD
Alitretinoin—RARA—Gene Expression—VDR—multiple sclerosis	9.27e-05	0.000407	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—VDR—multiple sclerosis	9.27e-05	0.000407	CbGpPWpGaD
Alitretinoin—Rash—Triamcinolone—multiple sclerosis	9.24e-05	0.000196	CcSEcCtD
Alitretinoin—Dermatitis—Triamcinolone—multiple sclerosis	9.23e-05	0.000196	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—multiple sclerosis	9.23e-05	0.000196	CcSEcCtD
Alitretinoin—Rash—Methylprednisolone—multiple sclerosis	9.22e-05	0.000196	CcSEcCtD
Alitretinoin—Dermatitis—Methylprednisolone—multiple sclerosis	9.21e-05	0.000196	CcSEcCtD
Alitretinoin—Urticaria—Prednisone—multiple sclerosis	9.2e-05	0.000195	CcSEcCtD
Alitretinoin—Headache—Triamcinolone—multiple sclerosis	9.18e-05	0.000195	CcSEcCtD
Alitretinoin—Headache—Methylprednisolone—multiple sclerosis	9.16e-05	0.000194	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—multiple sclerosis	9.16e-05	0.000194	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—multiple sclerosis	9.16e-05	0.000194	CcSEcCtD
Alitretinoin—Diarrhoea—Dexamethasone—multiple sclerosis	9.1e-05	0.000193	CcSEcCtD
Alitretinoin—Diarrhoea—Betamethasone—multiple sclerosis	9.1e-05	0.000193	CcSEcCtD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.07e-05	0.000398	CbGpPWpGaD
Alitretinoin—Hypotension—Methotrexate—multiple sclerosis	9.04e-05	0.000192	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—multiple sclerosis	8.9e-05	0.000391	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.82e-05	0.000187	CcSEcCtD
Alitretinoin—Dizziness—Dexamethasone—multiple sclerosis	8.79e-05	0.000187	CcSEcCtD
Alitretinoin—Dizziness—Betamethasone—multiple sclerosis	8.79e-05	0.000187	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—RPL5—multiple sclerosis	8.78e-05	0.000386	CbGpPWpGaD
Alitretinoin—Insomnia—Methotrexate—multiple sclerosis	8.75e-05	0.000186	CcSEcCtD
Alitretinoin—Nausea—Triamcinolone—multiple sclerosis	8.71e-05	0.000185	CcSEcCtD
Alitretinoin—RXRA—Metabolism—RRM1—multiple sclerosis	8.7e-05	0.000382	CbGpPWpGaD
Alitretinoin—Paraesthesia—Methotrexate—multiple sclerosis	8.69e-05	0.000185	CcSEcCtD
Alitretinoin—Nausea—Methylprednisolone—multiple sclerosis	8.69e-05	0.000184	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—multiple sclerosis	8.63e-05	0.000183	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—multiple sclerosis	8.6e-05	0.000183	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—POMC—multiple sclerosis	8.53e-05	0.000375	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—POMC—multiple sclerosis	8.53e-05	0.000375	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisone—multiple sclerosis	8.53e-05	0.000181	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—multiple sclerosis	8.52e-05	0.000181	CcSEcCtD
Alitretinoin—Vomiting—Dexamethasone—multiple sclerosis	8.46e-05	0.000179	CcSEcCtD
Alitretinoin—Vomiting—Betamethasone—multiple sclerosis	8.46e-05	0.000179	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—multiple sclerosis	8.41e-05	0.000179	CcSEcCtD
Alitretinoin—Rash—Dexamethasone—multiple sclerosis	8.39e-05	0.000178	CcSEcCtD
Alitretinoin—Rash—Betamethasone—multiple sclerosis	8.39e-05	0.000178	CcSEcCtD
Alitretinoin—Dermatitis—Dexamethasone—multiple sclerosis	8.38e-05	0.000178	CcSEcCtD
Alitretinoin—Dermatitis—Betamethasone—multiple sclerosis	8.38e-05	0.000178	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.36e-05	0.000177	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	8.35e-05	0.000367	CbGpPWpGaD
Alitretinoin—Fatigue—Methotrexate—multiple sclerosis	8.34e-05	0.000177	CcSEcCtD
Alitretinoin—Headache—Betamethasone—multiple sclerosis	8.33e-05	0.000177	CcSEcCtD
Alitretinoin—Headache—Dexamethasone—multiple sclerosis	8.33e-05	0.000177	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	8.32e-05	0.000365	CbGpPWpGaD
Alitretinoin—Asthenia—Prednisone—multiple sclerosis	8.31e-05	0.000176	CcSEcCtD
Alitretinoin—Pain—Methotrexate—multiple sclerosis	8.28e-05	0.000176	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.23e-05	0.000361	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.23e-05	0.000361	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.23e-05	0.000361	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—multiple sclerosis	8.21e-05	0.000361	CbGpPWpGaD
Alitretinoin—Pruritus—Prednisone—multiple sclerosis	8.19e-05	0.000174	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—multiple sclerosis	8.14e-05	0.000358	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.03e-05	0.000353	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.01e-05	0.000352	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	8e-05	0.000351	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.99e-05	0.000351	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—multiple sclerosis	7.98e-05	0.000351	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	7.98e-05	0.000351	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Methotrexate—multiple sclerosis	7.98e-05	0.000169	CcSEcCtD
Alitretinoin—Diarrhoea—Prednisone—multiple sclerosis	7.92e-05	0.000168	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.91e-05	0.000168	CcSEcCtD
Alitretinoin—Nausea—Betamethasone—multiple sclerosis	7.9e-05	0.000168	CcSEcCtD
Alitretinoin—Nausea—Dexamethasone—multiple sclerosis	7.9e-05	0.000168	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.86e-05	0.000345	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.83e-05	0.000344	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—multiple sclerosis	7.78e-05	0.000342	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—multiple sclerosis	7.78e-05	0.000342	CbGpPWpGaD
Alitretinoin—Urticaria—Methotrexate—multiple sclerosis	7.69e-05	0.000163	CcSEcCtD
Alitretinoin—Dizziness—Prednisone—multiple sclerosis	7.66e-05	0.000163	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—multiple sclerosis	7.65e-05	0.000336	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—multiple sclerosis	7.65e-05	0.000336	CbGpPWpGaD
Alitretinoin—Body temperature increased—Methotrexate—multiple sclerosis	7.65e-05	0.000162	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—multiple sclerosis	7.65e-05	0.000162	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.48e-05	0.000329	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	7.45e-05	0.000327	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.45e-05	0.000327	CbGpPWpGaD
Alitretinoin—Vomiting—Prednisone—multiple sclerosis	7.36e-05	0.000156	CcSEcCtD
Alitretinoin—Rash—Prednisone—multiple sclerosis	7.3e-05	0.000155	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—multiple sclerosis	7.3e-05	0.000155	CcSEcCtD
Alitretinoin—Headache—Prednisone—multiple sclerosis	7.26e-05	0.000154	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—multiple sclerosis	7.13e-05	0.000151	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.04e-05	0.000309	CbGpPWpGaD
Alitretinoin—Asthenia—Methotrexate—multiple sclerosis	6.94e-05	0.000147	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—PGR—multiple sclerosis	6.91e-05	0.000304	CbGpPWpGaD
Alitretinoin—Nausea—Prednisone—multiple sclerosis	6.88e-05	0.000146	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—multiple sclerosis	6.85e-05	0.000145	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.75e-05	0.000297	CbGpPWpGaD
Alitretinoin—Diarrhoea—Methotrexate—multiple sclerosis	6.62e-05	0.000141	CcSEcCtD
Alitretinoin—ABCB1—Metabolism—SRM—multiple sclerosis	6.51e-05	0.000286	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	6.49e-05	0.000285	CbGpPWpGaD
Alitretinoin—Dizziness—Methotrexate—multiple sclerosis	6.4e-05	0.000136	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.31e-05	0.000277	CbGpPWpGaD
Alitretinoin—Vomiting—Methotrexate—multiple sclerosis	6.15e-05	0.000131	CcSEcCtD
Alitretinoin—Rash—Methotrexate—multiple sclerosis	6.1e-05	0.00013	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—multiple sclerosis	6.1e-05	0.000129	CcSEcCtD
Alitretinoin—Headache—Methotrexate—multiple sclerosis	6.06e-05	0.000129	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	6.06e-05	0.000266	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.8e-05	0.000255	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TYK2—multiple sclerosis	5.77e-05	0.000253	CbGpPWpGaD
Alitretinoin—Nausea—Methotrexate—multiple sclerosis	5.75e-05	0.000122	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.58e-05	0.000245	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.29e-05	0.000232	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SRM—multiple sclerosis	5.2e-05	0.000228	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.03e-05	0.000221	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—BCHE—multiple sclerosis	5e-05	0.00022	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—VDR—multiple sclerosis	4.83e-05	0.000212	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.82e-05	0.000212	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.59e-05	0.000202	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.59e-05	0.000202	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—multiple sclerosis	4.54e-05	0.0002	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—multiple sclerosis	4.29e-05	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPC5—multiple sclerosis	4.2e-05	0.000184	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—multiple sclerosis	4.04e-05	0.000177	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—multiple sclerosis	3.99e-05	0.000175	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—multiple sclerosis	3.92e-05	0.000172	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—multiple sclerosis	3.84e-05	0.000169	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—multiple sclerosis	3.75e-05	0.000164	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—multiple sclerosis	3.69e-05	0.000162	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—multiple sclerosis	3.69e-05	0.000162	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK1—multiple sclerosis	3.67e-05	0.000161	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.66e-05	0.000161	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.66e-05	0.000161	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.58e-05	0.000157	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—multiple sclerosis	3.5e-05	0.000154	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RRM1—multiple sclerosis	3.48e-05	0.000153	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.35e-05	0.000147	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.21e-05	0.000141	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.2e-05	0.000141	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.14e-05	0.000138	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—multiple sclerosis	3.01e-05	0.000132	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.99e-05	0.000131	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—multiple sclerosis	2.82e-05	0.000124	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.78e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—multiple sclerosis	2.58e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—multiple sclerosis	2.36e-05	0.000103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.15e-05	9.46e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.01e-05	8.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BCHE—multiple sclerosis	2e-05	8.77e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—multiple sclerosis	1.92e-05	8.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.85e-05	8.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.69e-05	7.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.59e-05	7e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—multiple sclerosis	1.2e-05	5.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—multiple sclerosis	1.03e-05	4.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—multiple sclerosis	9.59e-06	4.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—multiple sclerosis	9.41e-06	4.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—multiple sclerosis	8.24e-06	3.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—multiple sclerosis	7.51e-06	3.3e-05	CbGpPWpGaD
